These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1280459

  • 1. Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen.
    Dumontet C, Bastion Y, Felman P, Ffrench M, Blanc M, Peaud PY, Coiffier B.
    Ann Oncol; 1992 Sep; 3(8):639-44. PubMed ID: 1280459
    [Abstract] [Full Text] [Related]

  • 2. [Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol].
    Dumontet C, Bastion Y, Felman P, Ffrench M, Blanc M, Peaud PY, Bryon PA, Coiffier B.
    Bull Cancer; 1992 Sep; 79(10):979-89. PubMed ID: 1284041
    [Abstract] [Full Text] [Related]

  • 3. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
    Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N.
    J Clin Oncol; 1989 Aug; 7(8):1018-26. PubMed ID: 2474057
    [Abstract] [Full Text] [Related]

  • 4. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
    Salles G, Herbrecht R, Tilly H, Berger F, Brousse N, Gisselbrecht C, Coiffier B.
    Am J Med; 1991 Jan; 90(1):77-84. PubMed ID: 1702581
    [Abstract] [Full Text] [Related]

  • 5. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
    Coiffier B, Bryon PA, Berger F, Archimbaud E, Ffrench M, Extra JM, Guyotat D, Fiere D, Gentilhomme O, Magaud JP.
    J Clin Oncol; 1986 Feb; 4(2):147-53. PubMed ID: 2418166
    [Abstract] [Full Text] [Related]

  • 6. Intensive chemotherapy in aggressive lymphomas: updated results of LNH-80 protocol and prognostic factors affecting response and survival.
    Coiffier B, Bryon PA, Ffrench M, Blanc M, Sebban C, Berger F, Viala JJ.
    Blood; 1987 Nov; 70(5):1394-9. PubMed ID: 2444287
    [Abstract] [Full Text] [Related]

  • 7. Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma after failure of the LNH 84 regimen.
    Herbrecht R, Ortiz S, Damonte JC, Liu KL, Maloisel F, Dufour P, Bergerat JP, Oberling F.
    Hematol Oncol; 1991 Nov; 9(4-5):253-7. PubMed ID: 1720760
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO.
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [Abstract] [Full Text] [Related]

  • 9. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
    Morel P, Dupriez B, Herbrecht R, Bastion Y, Tilly H, Delannoy A, Haioun C, Nouvel C, Bouabdallah K, Baumelou E.
    Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
    Bosly A, Coiffier B, Gisselbrecht C, Tilly H, Auzanneau G, Andrien F, Herbrecht R, Legros M, Devaux Y, Jaubert J.
    J Clin Oncol; 1992 Oct; 10(10):1615-23. PubMed ID: 1383435
    [Abstract] [Full Text] [Related]

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 12. Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Herbrecht R, Damonte JC, Dufour P, Maloisel F, Liu KL, Ortiz S, Bergerat JP, Oberling F.
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):7-10. PubMed ID: 1384135
    [Abstract] [Full Text] [Related]

  • 13. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
    Lee AY, Connors JM, Klimo P, O'Reilly SE, Gascoyne RD.
    J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol].
    Salles G, Herbrecht R, Brice P, Sebbań C, Tilly H, Lederlin P, Berger F, Coiffier B.
    Ann Gastroenterol Hepatol (Paris); 1992 May; 28(4):205-8. PubMed ID: 1280028
    [Abstract] [Full Text] [Related]

  • 15. Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survival.
    Licht JD, Bosserman LD, Andersen JW, Yeap BY, Klatt MM, Martel JK, Anderson KC, Rosenthal DS, Pinkus G, Skarin AT.
    Cancer; 1990 Aug 15; 66(4):632-9. PubMed ID: 1696844
    [Abstract] [Full Text] [Related]

  • 16. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.
    Lee R, Cabanillas F, Bodey GP, Freireich EJ.
    J Clin Oncol; 1986 Oct 15; 4(10):1455-61. PubMed ID: 2428947
    [Abstract] [Full Text] [Related]

  • 17. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
    Colombat P, Guilhot F, Bordesoule D, Renou P, Benz-Lemoine E, Fouillard L, Drouet M, Tanzer J, Lamagnere JP.
    Haematologica; 1991 Oct 15; 76(6):479-84. PubMed ID: 1726492
    [Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
    Gisselbrecht C, Oksenhendler E, Tirelli U, Lepage E, Gabarre J, Farcet JP, Gastaldi R, Coiffier B, Thyss A, Raphael M.
    Am J Med; 1993 Aug 15; 95(2):188-96. PubMed ID: 7689296
    [Abstract] [Full Text] [Related]

  • 19. VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Herbrecht R, Garcia JJ, Bergerat JP, Dufour P, Duclos B, Oberling F.
    Cancer Chemother Pharmacol; 1989 Aug 15; 24(5):338-9. PubMed ID: 2474382
    [Abstract] [Full Text] [Related]

  • 20. Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
    Oksenhendler E, Gerard L, Dubreuil ML, Levy Y, Matheron S, Cazals-Hatem D, Chevret S, Clauvel JP.
    Leuk Lymphoma; 2000 Sep 15; 39(1-2):87-95. PubMed ID: 10975387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.